Abstract:Objective: N-methyl-d-aspartate (NMDA) receptors are expressed at synaptic sites, where they mediate fast excitatory neurotransmission. NMDA receptors are critical to brain development and cognitive function. Natural variants to the GRIN1 gene, which encodes the obligatory GluN1 subunit of the NMDA receptor, are associated with severe neurological disorders that include epilepsy, intellectual disability, and developmental delay. Here, we investigated the pathogenicity of three missense variants to the GRIN1 gene, p. Ile148Val (GluN1-3b[I481V]), p.Ala666Ser (GluN1-3b[A666S]), and p.Tyr668His (GluN1-3b[Y668H]). Methods: Wild-type and variant-containing NMDA receptors were expressed in HEK293 cells and primary hippocampal neurons. Patch-clamp electrophysiology and pharmacology were used to profile the functional properties of the receptors. Receptor surface expression was evaluated using fluorescently tagged receptors and microscopy. Results: Our data demonstrate that the GluN1(I481V) variant is inhibited by the open pore blockers ketamine and memantine with reduce potency but otherwise has little effect on receptor function. By contrast, the other two variants exhibit gain-of-function molecular phenotypes. Glycine sensitivity was enhanced in receptors containing the GluN1(A666S) variant and the potency of pore block by memantine and ketamine was reduced, whereas that for MK-801 was increased. The most pronounced functional deficits, however, were found in receptors containing the GluN1(Y668H) variant. GluN1(Y668H)/2A receptors showed impaired surface expression, were more sensitive to glycine and glutamate by an order of magnitude, and exhibited impaired block by extracellular magnesium ions, memantine, ketamine, and MK-801. These variant receptors were also activated by either glutamate or glycine alone. Single-receptor recordings revealed that this receptor variant opened to several conductance levels and activated more frequently than wild-type GluN1/2A receptors. Significance: Our study reveals a critical functional locus of the receptor (GluN1[Y668]) that couples receptor gating to ion channel conductance, which when mutated may be associated with neurological disorder.

Lack of evidence for direct ligand-gated ion channel activity of GluD receptors

Mutations Linked to Generalized Epilepsy in Humans Reduce GABA(A) Receptor Current.

Potentiation of neuronal activity by tonic GluD1 current in brain slices

Mechanisms underlying the synaptic trafficking of the glutamate delta receptor GluD1

Evidence that glutamate acting on presynaptic type-II metabotropic glutamate receptors alone does not fully account for the phenomenon of depolarisation-induced suppression of inhibition in cerebellar Purkinje cells

Independent regulation of early trafficking of NMDA receptors by ligand-binding domains of the GluN1 and GluN2A subunits

Constitutive activity of ionotropic glutamate receptors via hydrophobic substitutions in the ligand-binding domain

Unmasking GluN1/GluN3A excitatory glycine NMDA receptors

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

The Lurcher Mutation Identifies d2 as an AMPA/Kainate Receptor- Like Channel That Is Potentiated by Ca21

Glycine agonism in ionotropic glutamate receptors

Excitatory and inhibitory D-serine binding to the NMDA receptor

Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel

Negative allosteric modulation of GluN1/GluN3 NMDA receptors

Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors

Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties

Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors

Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists

GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms

Cysteine Residues 87 and 320 in the Amino Terminal Domain of Nmda Receptor Glun2a Govern Its Homodimerization but Do Not Influence Glun2a/Glun1 Heteromeric Assembly

Glua2 (Glur2) Regulates Metabotropic Glutamate Receptor-Dependent Long-Term Depression Through N-Cadherin-Dependent And Cofilin-Mediated Actin Reorganization